Liu Li

Liu Li


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2023 in Cancers
Verified
Journal Article
Open access
PDF file
QDQing Dan
Qing Dan
TZTingting Zheng
Tingting Zheng
LLLiu Li
Liu Li
DSDeshen Sun
Deshen Sun
YCYun Chen
Yun Chen
Breast cancer (BC) is the most prevalent cancer among women globally. Cancer screening can reduce mortality and improve women’s health. In developed countries, mammography (MAM) has been primarily utilized for population-based BC screening for several decades. However, it is usually unavailable in low-resource settings due to the lack of equipment, personnel, and time necessary to conduct and interpret the examinations. Ultrasound (US) with high detection sensitivity for women of younger ages and with dense breasts has become a supplement to MAM for breast examination. Some guidelines suggest using US as the primary screening tool in certain settings where MAM is unavailable and infeasible, but global recommendations have not yet reached a unanimous consensus. With the development of smart devices and artificial intelligence (AI) in medical imaging, clinical applications and preclinical studies have shown the potential of US combined with AI in BC screening. Nevertheless, there are few comprehensive reviews focused on the role of US in screening BC in underserved conditions, especially in technological, economical, and global perspectives. This work presents the benefits, limitations, advances, and future directions of BC screening with technology-assisted and resource-appropriate strategies, which may be helpful to implement screening initiatives in resource-limited countries.

6 February 2024 in Biomaterials Science
Verified
Journal Article
Open access
PDF file
PLPing Li
Ping Li
XTXiao Tan
Xiao Tan
QDQing Dan
Qing Dan
AHAzhen Hu
Azhen Hu
ZHZhengming Hu
Zhengming Hu
TZTingting Zheng
Tingting Zheng
Sono-photodynamic therapy (SPDT) has emerged as a promising treatment modality for triple negative breast cancer (TNBC). However, the hypoxic tumor microenvironment hinders the application of SPDT. Herein, in this study, a multifunctional platform (MnO2/Ce6@MBs) was designed to address this issue. A sono-photosensitizer (Ce6) and a hypoxia modulator (MnO2) were loaded into microbubbles and precisely released within tumor tissues under ultrasound irradiation. MnO2 in situ reacted with the excess H2O2 and H+ and produced O2 within the TNBC tumor, which alleviated hypoxia and augmented SPDT by increasing ROS generation. Meanwhile, the reaction product Mn2+ was able to achieve T1-weighted MRI for enhanced tumor imaging. Additionally, Ce6 and microbubbles served as a fluorescence imaging contrast agent and a contrast-enhanced ultrasound imaging agent, respectively. In in vivo anti-tumor studies, under the FL/US/MR imaging guidance, MnO2/Ce6@MBs combined with SPDT significantly reversed tumor hypoxia and inhibited tumor growth in 4T1-tumor bearing mice. This work presents a theragnostic system for reversing tumor hypoxia and enhancing TNBC treatment.

24 October 2024 in Biomaterials Science
Verified
Journal Article
Open access
PDF file
LXLijun Xing
Lijun Xing
XYXiaoting Yang
Xiaoting Yang
JBJianhua Bai
Jianhua Bai
CZChunting Zhong
Chunting Zhong
JCJing Cai
Jing Cai
TZTingting Zheng
Tingting Zheng
Early diagnosis of liver cancer and appropriate treatment options are critical for obtaining a good prognosis.

18 December 2025 in Immunologic Research
Verified
Journal Article
Open access
PDF file
YSYansun Sun
Yansun Sun
LWLing Wang
Ling Wang
LLLiu Li
Liu Li
YSYansun Sun
Yansun Sun
Background Cardiovascular-kidney-metabolic (CKM) syndrome is a major public health concern associated with increased mortality. Inflammation plays a critical role in CKM progression and outcomes. This study investigates the relationship between inflammatory indices and mortality risk in CKM patients. Methods A comprehensive analysis of data from 26,265 participants in the National Health and Nutrition Examination Survey (NHANES) database (2007–2016) with CKM syndrome stages 0–4 was conducted. The primary outcomes of the study were all-cause and cardiovascular mortality. The inflammatory indices encompassed the systemic inflammation response index (SIRI), neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), aggregate index of systemic inflammation (AISI), and neutrophil-to-albumin ratio (NAR). Multivariable Cox models, adjusted for demographic and clinical confounders, were employed to examine nonlinearity, alongside restricted cubic splines and threshold analyses. The present study sought to compare the prognostic accuracy of the time-dependent ROC (Receiver Operating Characteristic) at 93 months. Results During a median follow-up of 93.4 months, 2,292 subjects experienced all-cause mortality and 701 experienced cardiovascular deaths. In the adjusted models, elevated SIRI (all-cause HR 1.11, 95% CI 1.06–1.15; cardiovascular HR 1.18, 1.10–1.27), NLR (all-cause HR 1.08, 1.05–1.12; cardiovascular HR 1.11, 1.05–1.17) and MLR (all-cause HR 2.27, 1.71–3.01; cardiovascular HR 3.37, 2.09–5.44) were independently associated with mortality (all p < 0.0001). Dose–response analyses revealed nonlinear J-shaped relationships: MLR showed marked risk above 0.19 (HR 2.59), NLR risk was greatest below 3 (HR 1.14), and SIRI thresholds differed for all-cause (> 1.74, HR 1.09) versus cardiovascular (> 0.38, HR 1.17) outcomes. At 93 months, MLR demonstrated the highest discriminatory ability (AUC 0.630; C-index 0.667; p < 0.001), outperforming SIRI (AUC 0.611) and NLR (AUC 0.602). PLR, AISI, SII and NAR showed limited predictive value due to imbalanced sensitivity–specificity. The impact of age and the early stages of CKD on the modification of associations was investigated. Conclusion Systemic inflammatory indices demonstrated nonlinear, J-shaped associations with mortality in CKM syndrome, with the MLR showing the strongest association across disease trajectories. MLR, NLR, and SIRI were identified as potential risk indicators, with stronger associations observed in younger patients and those with early-stage CKM syndrome. Highlights Systemic inflammatory markers (SIRI, NLR, MLR) were significantly associated with increased mortality risk in CKM syndrome. Most inflammation indices exhibited nonlinear, J-shaped associations with mortality. Nonlinear threshold analyses identified specific risk inflection points for SIRI, NLR, and MLR. These associations were stronger in younger patients (≤ 60 years) and those with early CKM stages (1–2).

4 December 2024 in Aging
Verified
Journal Article
Open access
PDF file
LXLiangliang Xu
Liangliang Xu
BLBo Li
Bo Li
YLYuchen Liu
Yuchen Liu
ZHZhengming Hu
Zhengming Hu
QDQing Dan
Qing Dan
LLLiu Li
Liu Li
Age-related cancers are characterized by impaired protein homeostasis, where Kelch protein superfamily members have showed accumulating clues as critical regulators. In this paper, the cancerous role of Kelch-like family member 23 (KLHL23) was comprehensively analyzed with TCGA and single cell GEO database across overall 33 cancer types. By multi-omics analysis upon the transcriptomic, genomic, and methylation data, the current study explored the association of KLHL23 with patient survival, gene ontology, tumor-infiltrating lymphocytes, and drug responses. The correlation of copy number variations and methylation with dysregulated expression of KLHL23 were also addressed. Notably, KLHL23 levels correlated with survival in cancers such as hepatocellular carcinoma and low-grade glioma. The study also highlighted how reduced KLHL23 expression is linked to increased immune activity and sensitivity to chemotherapy, suggesting its potential as a biomarker for cancer prognosis and treatment responsiveness.

16 February 2024 in Biomaterials Science
Verified
Journal Article
Open access
PDF file
PLPing Li
Ping Li
XTXiao Tan
Xiao Tan
QDQing Dan
Qing Dan
AHAzhen Hu
Azhen Hu
ZHZhengming Hu
Zhengming Hu
TZTingting Zheng
Tingting Zheng
Correction for ‘MnO2/Ce6 microbubble-mediated hypoxia modulation for enhancing sono-photodynamic therapy against triple negative breast cancer’ by Ping Li et al., Biomater. Sci., 2024, https://doi.org/10.1039/d3bm00931a.